期刊文献+

mTOR抑制剂-雷帕霉素对树突状细胞功能调控的研究进展 被引量:2

Research advances in the study of the regulatory effect of mTOR inhibitor-rapamycin on dendritic cells
原文传递
导出
摘要 哺乳动物雷帕霉素靶蛋白(mTOR)作为信号通路的调节器能形成细胞对各种刺激的应答,而雷帕霉素则是通过阻断mTOR参与的信号转导阻止DC的功能从而发挥其免疫抑制作用.免疫细胞能通过表面受体直接或间接地向mTOR传导信号,调节免疫应答.研究表明:mTOR可调控不同种类的抗原提呈细胞(APC),如树突状细胞(DC)的分化与成熟、存活、迁移、抗原摄取与应答以及细胞因子产生等,对固有免疫和适应性免疫都有重要的调节作用. The mammalian target of rapamycin (mTOR) in innate and adaptive immune responses is becoming apparent. mTOR regulates diverse functions of dendritic cells (DCs), such as DC differentiation,maturation, survival, migration, antigen uptake and presentation, and cytokine production. The immunosuppressive effect of rapamycin is achieved by inhibiting mTOR and impairing the maturation and functions of DC.
作者 王野 钱程
出处 《国际免疫学杂志》 CAS 北大核心 2010年第5期392-395,共4页 International Journal of Immunology
关键词 雷帕霉素靶蛋白 雷帕霉素 树突状细胞 功能调控 Mammalian target of rapamycin Rapamycin Dendritic cell Functional regulation
  • 相关文献

参考文献20

  • 1Kahan BD,Mandelbrot DA,Oberbauer R,et al.mTOR inhibition:the learning curve in kidney transplantation.Transpl Int,2010,23(5):447-460.
  • 2侯桂敏,谷金宇.哺乳动物雷帕霉素靶蛋白抑制剂联合其它抗肿瘤药物治疗肿瘤的研究进展[J].国际免疫学杂志,2010,33(1):9-11. 被引量:3
  • 3De Meyer GR,Croons V,Martinet W.Selective removal of macrophages in atherosclerotic plaques as a pharmacological approach for plaque stabilization:benefits versus potential complications.Curr Vasc Pharmacol,2010,8(4):495-508.
  • 4Foster KG,Fingar DC.Mammalian target of rapamycin(mTOR):conducting the cellular signaling symphony.J Biol Chem,2010,285(19):14071-14077.
  • 5S(a)emann MD,Haidinger M,Hecking M,et al.The Multifunctional Role of mTOR in Innate Immunity:Implications for Transplant Immunity.Am J Transplant,2009,9(12):2655-2661.
  • 6Fingar DC,Feener EP,Ballif BA,et al.Site-specific mTOR phosphorylation promotes mTORC1-mediated signaling and cell growth.Mol Cell Biol,2009,29(15):4308-4324.
  • 7Yip CK,Murata K,Walz T,et al.Structure of the human mTOR complex Ⅰ and its implications for rapamycin inhibition.Mol Cell,2010,38(5):768-774.
  • 8Bhagwat SV,Crew AP.Novel inhibitors of mTORC1 and mTORC2.Curr Opin Investig Drugs,2010,11(6):638-645.
  • 9Park S,Zhao D,Hatanpaa KJ,et al.RIP1 activates PI3K-Akt via a dual mechanism involving NF-kappaB-mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop and down-regulation of PTEN.Cancer Res,2009,69(10):4107-4111.
  • 10Xiang XS,Zhao YZ,Li N,et al.Accumulation of DC in lamina propria induced by FMS-like tyrosine kinase 3 ligand aggravates the intestinal inflammatory response during endotoxemia.Inflammation,2010,33(1):34-45.

二级参考文献18

  • 1Cao P, Maira SM, Garcia-Eeheverria C, et al. Dual P13-kinase/mTor inhibitor NVP-BEZ235 against primarry human pancreatic cancers grown as orthotopic xenografts. Br J Cancer, 2009, 100 (8) :1267-1276.
  • 2Schmelzle T, Hall MN. TOR, a central controller of cell growth. Cell, 2000, 103 ( 2 ) :253-262.
  • 3Daniel Morgensztern, Howard L. MeLeod. PI3K/Akt/mTOR pathway as a target for cancer therapy, Antieaneer Drugs, 2005,16 (8) : 797 -803.
  • 4Konings IR, Verweij J, Wiemer EA, et al. The applicability of roTOR iahibition in solid tumors. Curr Cancer Drug Targets, 2009,9(3):439-450.
  • 5Ellard SL, Ctemuns M, Gelmon KA, et al. Randomized phase Ⅱ study comparing two schedules of everolimus in patients with recurrent/metastatic breast cancer: NCIC Clinical Trials Group IND. 163. J Clin Oncol, 2009, 27(27) :4536-4541.
  • 6Fasolo A, Sessa C. roTOR inhibitors in the treatment of cancer. Expert Opin Investig Drugs, 2008,17 ( 11 ) : 1717-1734.
  • 7Hess G, Herhrecht R, Romaguera J, et al. Phase Ⅲ study to evaluate temsirolimus compared with investigator's ehoiee therapy for the treatment of relapsed or refractor' mantle celt lyrnphoma. J Clin Oncol, 2009, 27 (23) :3822-3829.
  • 8Kapoor A, Figlin RA. Targeted inhibition of mammalian target of rapamycin for the treatment of advanced renal cell carcinoma. Cancer, 2009, 115 (16):3618-3630.
  • 9Vander Weele DJ, Zhou R, et al. Akt up-regulation increases resistanee to microtubule-directed chemotherapeutic agents through mammalian target of rapamyein. Mol Cancer Ther, 2004,3 ( 12 ) : 1605-1613.
  • 10Yu C, Mao X, Li WX. Inhibition of the PI3K pathway sensitizes fludarabine-induced apoptosis in human leukemic cells through an inactivation of MAPK-dependent pathway. Biochemi Biophys Res Commun, 2005, 331 (2) :391-397.

共引文献2

同被引文献2

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部